<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Morgan Waugh | Activity</title>
	<link>https://www.catswannabecats.com/members/hatpastry7/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/hatpastry7/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Morgan Waugh.</description>
	<lastBuildDate>Sat, 04 Jul 2026 08:03:39 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">88f8986c69a5649c3082083c99b94384</guid>
				<title>Morgan Waugh posted an update: PI3Kα has been identified as an ideal target to treat with [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/7278/</link>
				<pubDate>Sat, 31 May 2025 18:40:07 -0400</pubDate>

									<content:encoded><![CDATA[<p>PI3Kα has been identified as an ideal target to treat with PIK3CA gene mutation disease, including drugs such as Alpelisib and Copanlisib. Five purine analogues and four thiazole analogues were designed and synthesized. Their enzymaticactivity against PI3Ka/β/γ/δ were tested, respectively. All compounds showed excellent selectivity in mod&hellip;<span class="activity-read-more" id="activity-read-more-7278"><a href="https://www.catswannabecats.com/activity/p/7278/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">85f9325cb2fa53721ff1bde5a70a0313</guid>
				<title>Morgan Waugh became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/6093/</link>
				<pubDate>Sat, 31 May 2025 15:48:56 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>